Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q4 2021 vs. Q3 2021
How the institutions holding Cidara Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 50 | 1 | 53 | +4 |
| Shares | 18.8M | 415.3K | 31.1M | +12.7M (+69.0%) |
| Value | $42.1M | $930.0K | $39.5M | −$1.73M (−4.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nantahala Capital Management, LLC | 5,270,458 | $6.69M | 0.42% |
| Point72 Asset Management, L.P. | 4,200,000 | $5.33M | 0.02% |
| Knott David M Jr | 428,896 | $545.0K | 0.21% |
| Laurion Capital Management LP | 198,635 | $252.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 118,040 | $150.0K | 0.00% |
| XTX Topco Ltd | 39,446 | $50.0K | 0.03% |
| Susquehanna International Group, LLP | 22,236 | $28.0K | 0.00% |
| Cetera Investment Advisers | 12,000 | $15.0K | 0.00% |
| Simplex Trading, LLC | 3,046 | $3.00K | 0.00% |
| Allworth Financial LP | 800 | $1.00K | 0.00% |
| Tyler-Stone Wealth Management | 750 | $1.00K | 0.00% |
| Castleview Partners, LLC | 6,986 | – | – |
Sold out (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Omega Fund Management, LLC | 2,005,249 | $4.49M |
| Jacobs Levy Equity Management, Inc | 594,705 | $1.33M |
| Monashee Investment Management LLC | 369,099 | $827.0K |
| Ergoteles LLC | 160,070 | $359.0K |
| Squarepoint Ops LLC | 87,419 | $196.0K |
| HRT Financial LP | 63,166 | $141.0K |
| Dimensional Fund Advisors LP | 12,326 | $28.0K |
| Group One Trading, L.P. | 11,548 | $26.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 415,308 | $930.0K |